Jiangsu Hengrui Pharmaceuticals (01276) spent 75,769,000 yuan on October 28 to repurchase 1,186,000 A shares.
Hengrui Medicine (01276) announced that it will spend 75.769 million yuan to repurchase 1...
Jiangsu Hengrui Pharmaceuticals (01276) announced on October 28, 2025 the repurchase of 1.186 million A-shares at a cost of 75.769 million yuan.
Related Articles
US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.
US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.
US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.
US Stock Market Move | Nucor Corporation (NUE.US) rose by more than 5.6% with Q3 net profit doubling year-on-year.
US Stock Market Move | Planned issuance of $1 billion in convertible senior notes Galaxy Digital (GLXY.US) plummeted by over 8%.
US Stock Market Move | Intel Corporation (INTC.US) rose more than 6%. The CEO said the company will focus on AI and contract manufacturing business.
RECOMMEND
Why European Automakers Are Opposing Dutch Sanctions
20/10/2025
Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025
Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025
